Washington University School of Medicine: Clinical Trials

2178 trials sponsored by Washington University School of Medicine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1232 completed, 285 terminated, 272 recruiting, 134 active not recruiting. 890 Not applicable, 432 Phase 2, 332 Phase 1, 97 Phase 3, 84 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable890Completed 544, Recruiting 112, Terminated 98, Active not recruiting 46, Withdrawn 32, Unknown 27, Not yet recruiting 19, Enrolling by invitation 11, Suspended 1
Phase 2432Completed 184, Terminated 80, Recruiting 55, Withdrawn 46, Active not recruiting 39, Not yet recruiting 19, Unknown 6, Suspended 2, Enrolling by invitation 1
Phase 1332Completed 171, Terminated 61, Recruiting 40, Withdrawn 22, Active not recruiting 21, Not yet recruiting 7, Suspended 5, Enrolling by invitation 3, Unknown 2
Phase 397Completed 67, Recruiting 10, Terminated 10, Active not recruiting 5, Withdrawn 2, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1
Phase 484Completed 54, Terminated 14, Withdrawn 8, Active not recruiting 3, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1
Early Phase 173Completed 47, Terminated 11, Recruiting 7, Withdrawn 4, Unknown 2, Active not recruiting 1, Not yet recruiting 1

Follow this sponsor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2
Motion Perception Task, Sine Wave Speech Task, Volatility Task - SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder
Not applicableNot yet recruitingWashington University School of Medicine3252028-04-012026-10-15
TeamTalk: Improving Inter-professional Communication During Cancer Treatment
Multi-level communication intervention - Pediatric Cancer
Not applicableNot yet recruitingWashington University School of Medicine82027-09-232026-01-07
Communication and Hospice Online With Optimal Support and Engagement
Intermittent Hospice Team Support, Online Support Group with untrained facilitator, Online Support Group with trained facilitator - Caregivers, Family Caregivers
Not applicableNot yet recruitingWashington University School of Medicine5672027-02-012026-08-14
Semaglutide for Low Back Pain
Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector) - Lower Back Pain, Obesity (BMI>30)
Phase 2Not yet recruitingWashington University School of Medicine2502027-02-012026-07-28
Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor
avutometinib capsule + defactinib tablet - MPNST (Malignant Peripheral Nerve Sheath Tumor)
Phase 2Not yet recruitingGirish Dhall, MD232027-01-012026-08-04
Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management
Contingency Management, Social Drivers of Health Screening - Pregnancy, Substance Use Disorder (SUD)
Phase 2Not yet recruitingWashington University School of Medicine2452027-01-012026-08-20
Social Media and Risk-reduction Training for Preterm Infant Care Practices
Safe Sleep NICU Quality Improvement Campaign, Shared Reading NICU Quality Improvement Campaign, Safe Sleep TodaysNICUBaby videos and messages - Safe Sleep Education, SUID
Not applicableNot yet recruitingUniversity of Massachusetts, Worcester16002027-01-012026-05-13
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Telaglenastat, Radiation treatment, Cisplatin - Advanced Cervical Carcinoma, Cervical Cancer
Phase 2Not yet recruitingWashington University School of Medicine422026-12-312026-09-03
Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer
Dabrafenib, Trametinib, Pembrolizumab - Anaplastic Thyroid Carcinoma, Thyroid Cancer
Phase 2Not yet recruitingWashington University School of Medicine122026-12-312026-10-21
MIRICURE: Mirikizumab With Curettage and Repair (Closure) for Perianal Fistulizing Crohn's Disease
Mirikizumab, Fistula Tract Curettage and Closure - Crohn's Disease, Perianal Fistula
Phase 4Not yet recruitingIcahn School of Medicine at Mount Sinai502026-12-012026-08-24
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Cemiplimab, Prednisone, Sirolimus - Kidney Transplant Recipient, Cutaneous Squamous Cell Carcinoma (CSCC)
Phase 2Not yet recruitingWashington University School of Medicine222026-11-302026-10-15
Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction
Restrata® - Breast Reconstruction, Deep Inferior Epigastric Perforator
Not applicableNot yet recruitingWashington University School of Medicine202026-11-302026-10-01
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer
Sipuleucel-T, N803 - Prostate Cancer, Metastatic Prostate Cancer
Phase 1Not yet recruitingWashington University School of Medicine302026-11-302026-08-10
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
NeuroBlate® Laser Ablation Laser Interstitial Thermal Therapy, Cemiplimab, Chemotherapy - Glioblastoma, Glioblastoma, IDH-wildtype
Phase 2Not yet recruitingWashington University School of Medicine992026-11-302026-10-20
Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms
Somatostatin Analogue(s) - Neuroendocrine Neoplasm, Gastroenteropancreatic Neuroendocrine Neoplasm
Phase 3Not yet recruitingWashington University School of Medicine2402026-11-302026-10-19
Low-Count Quantitative SPECT for Men Treated With Radium-223
Low-count quantitative single-photon emission computed tomography imaging - Prostate Cancer, Cancer of the Prostate
Not applicableRecruitingWashington University School of Medicine382026-11-012026-10-15
Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity
68Ga-Galmydar, PET/MRI, 18F-FDG - Lymphoma Cancer, Breast Cancer
Phase 1Not yet recruitingWashington University School of Medicine362026-11-012026-09-24
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
1-(4-(2-Fluoroethoxy)phenyl)-8,9-dihiydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one, FTT-PET/CT, EnhanceAR-Seq - Metastatic Prostate Cancer, Prostate Cancer
Phase 2Not yet recruitingWashington University School of Medicine752026-11-012026-10-21
Asciminib With or Without Sildenafil for Brain Tumors
Asciminib, Sildenafil, Surgical resection or biopsy - Brain Tumor
Early Phase 1Not yet recruitingWashington University School of Medicine122026-10-312026-09-11
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma
64Cu-DOTA-ECL1i - Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Phase 2RecruitingWashington University School of Medicine902026-10-312026-10-07

Showing 20 of 2178. Sign in to see all of them.

Conditions studied

Obesity (98)  ·  Breast Neoplasms (86)  ·  Depression (57)  ·  Diabetes Mellitus (50)  ·  Neoplasms (47)  ·  Leukemia, Myeloid, Acute (43)  ·  Motor Activity (42)  ·  Multiple Myeloma (40)  ·  Pancreatic Neoplasms (37)  ·  Parkinson Disease (36)  ·  Diabetes Mellitus, Type 2 (31)  ·  Carcinoma, Non-Small-Cell Lung (30)  ·  Myelodysplastic Syndromes (30)  ·  Cardiovascular Diseases (29)  ·  Prostatic Neoplasms (28)

Interventions

Blood Specimen Collection (30)  ·  Exercise (22)  ·  Standard of Care (22)  ·  Fluorouracil (21)  ·  Gemcitabine (20)  ·  Cisplatin (19)  ·  Granulocyte Colony-Stimulating Factor (19)  ·  Radiotherapy (19)  ·  pembrolizumab (19)  ·  Carboplatin (18)  ·  Nivolumab (17)  ·  Cyclophosphamide (16)  ·  Dexamethasone (16)  ·  Cytarabine (15)  ·  Filgrastim (15)

Countries

United States (1918)  ·  Canada (52)  ·  Malawi (26)  ·  Nigeria (18)  ·  Uganda (17)  ·  Australia (12)  ·  Ghana (12)  ·  United Kingdom (12)  ·  Sierra Leone (10)  ·  Bangladesh (9)  ·  Italy (9)  ·  Spain (9)  ·  France (8)  ·  Germany (8)  ·  Colombia (7)

Top investigators

Samuel Klein, MD (28)  ·  Ravi Vij, M.D. (18)  ·  Jay F Piccirillo, MD (17)  ·  Mark J Manary, MD (15)  ·  Mark Manary, MD (14)  ·  Douglas Adkins, M.D. (12)  ·  Simon Haroutounian, PhD (12)  ·  Eric Lenze, MD (11)  ·  Ramaswamy Govindan, M.D. (11)  ·  Farrokh Dehdashti, M.D. (9)  ·  Amanda Cashen, M.D. (8)  ·  Daniel Morgensztern, M.D. (8)  ·  Eric J Lenze, MD (8)  ·  Jiayi Huang, M.D. (8)  ·  Michael S Avidan, MBBCh (8)

Results publications

PMID 31004409, PMID 33512717, PMID 34905513, PMID 37585253, PMID 38569683, PMID 42714910, PMID 12150647, PMID 15367925, PMID 17375138, PMID 18317237, PMID 18383112, PMID 18477783, PMID 19647838, PMID 19948045, PMID 20208057, PMID 20539253, PMID 21334602, PMID 21818149, PMID 22222548, PMID 22337229, PMID 22526637, PMID 22710617, PMID 23166334, PMID 23522057, PMID 23817024, PMID 24657120, PMID 24852500, PMID 24871971, PMID 25018070, PMID 25273286, PMID 25475435, PMID 25712598, PMID 25979608, PMID 26160288, PMID 26200928, PMID 26494483, PMID 26578308, PMID 27067170, PMID 28292947, PMID 28406662, PMID 28433500, PMID 28473464, PMID 28740827, PMID 28797458, PMID 29294006, PMID 29400693, PMID 29515037, PMID 29955682, PMID 30260448, PMID 30704863

NIH funding

P50CA171963 (7), UL1TR002345 (7), P50MH122351 (6), P30CA091842 (5), P50CA196510 (5), U01AG059798 (5), K12CA167540 (4), KL2TR002346 (4), R01AG046179 (4), U01AG042791 (4), R01AG053267 (3), R01DK088126 (3), R01ES033743 (3), R01HD085930 (3), R01HL144708 (3)